SEC Form 4 · accession 0001144204-15-054881
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Avgerinos
Officer — SVP, Biologics Operations
Period of report
Sep 10, 2015
Accepted (ET)
Sep 14, 2015 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001F1 | Sep 10, 2015 | D | 22,737 | $2.6193 | D | 189,299 | D | |
| Common Stock, par value $0.001F2 | Sep 11, 2015 | D | 31,299 | $2.6806 | D | 158,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $2.58 to $2.68. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
- F2This transaction was executed in multiple trades at prices ranging from $2.60 to $2.75. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.